The list price set by manufacturer Novo Nordisk is $1,027.51 per month for a one-month supply of the 0.25 mg or 0.5 mg pen
Protocol Overview Starting Phase (Weeks 14) 1.52.5 mg(4 doses) During this phase, the body begins adjusting to the compound
GLP-1 treatment for diabetes and obesity Semaglutide, a GLP-1 receptor agonist, is the active ingredient in Ozempic for diabetes and in Wegovy for obesity
If pregnant or nursing, please consult your healthcare professional
Three regulators, no clear owner When a patient sees a Medvi ad on social media, clicks through, fills out an intake form, is prescribed a compounded GLP-1 by a physician theyve never met and receives medicine from a pharmacy, at least three federal regulatory agencies oversee that interaction, plus the relevant state medical board and possibly the FTCs digital advertising division
The local site reaction includes bruising, discoloration, induration, and pain (130)